| Dr Satinderjit Singh, MD | |
|
1000 4th St Sw, Mason City, IA 50401-2800 | |
| (641) 428-7234 | |
| (641) 428-6373 |
| Full Name | Dr Satinderjit Singh |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1000 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013203199 | NPI | - | NPPES |
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
diaDexus, Inc., a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the third quarter of 2010.
Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
AstraZeneca today announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC).
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the second quarter and six months ended June 30, 2009.
› Verified 8 days ago
| Entity Name | Franklin General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720296775 PECOS PAC ID: 5799693925 Enrollment ID: O20031203000072 |
News Archive
diaDexus, Inc., a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the third quarter of 2010.
Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
AstraZeneca today announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC).
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the second quarter and six months ended June 30, 2009.
› Verified 8 days ago
| Entity Name | Mercy Medical Center New Hampton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679641419 PECOS PAC ID: 9032006325 Enrollment ID: O20040302000403 |
News Archive
diaDexus, Inc., a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the third quarter of 2010.
Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
AstraZeneca today announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC).
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the second quarter and six months ended June 30, 2009.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Satinderjit Singh, MD 621 S Illinois Ave, Suite 103, Mason City, IA 50401-5489 Ph: (641) 428-3041 | Dr Satinderjit Singh, MD 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 428-7234 |
News Archive
diaDexus, Inc., a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the third quarter of 2010.
Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
AstraZeneca today announced enrolment of the first patient in the Phase III clinical programme for NKTR-118, an oral peripherally-acting opioid antagonist being investigated for the treatment of opioid-induced constipation (OIC).
PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the second quarter and six months ended June 30, 2009.
› Verified 8 days ago
Paul H Gordon, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 4th St Sw, Mason City, IA 50401 Phone: 641-422-6020 Fax: 641-422-7803 | |
Dr. Brian Michael Kuchay, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 621 S Illinois Ave, Mason City, IA 50401 Phone: 641-428-7234 | |
William I Parker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 4th St Sw, Suite Er, Mason City, IA 50401 Phone: 641-422-7234 Fax: 641-422-6373 | |
Tavi J Madden-leduc, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-422-7234 Fax: 641-422-6373 | |
Dr. Rajendra Singh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Suite Er, Mason City, IA 50401 Phone: 641-422-7234 Fax: 641-422-6373 | |
Dr. Matthew J Schiller, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 4th St Sw, Suite Er, Mason City, IA 50401 Phone: 641-422-7234 Fax: 641-422-6373 |